Sirolimus - Wikipedia

Sirolimus, also known as rapamycin, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection and to treat a rare lung disease ...

Sirolimus — Wikipédia

Le sirolimus, appelé également rapamycine, est un médicament qui, comme la ciclosporine et le tacrolimus, est classé parmi les immunosuppresseurs.

Sirolimus – Wikipedia

Anwendungen. Sirolimus wird nach Nierentransplantationen, meist in Kombination mit Ciclosporin und Corticosteroiden, zur Verhinderung einer Organabstoßung eingesetzt.

Rapamycin (Sirolimus) | Licensed by Pfizer | mTOR inhibitor

Rapamycin also known as Sirolimus & Rapamune is an mTOR inhibitor. Rapamycin Sirolimus inhibits cell motility by suppression of mTOR-mediated pathways. Find all the ...

Sirolimus - Wikipedia, la enciclopedia libre

El sirolimus (INN, también conocido como rapamicina, es un medicamento inmunosupresor usado para evitar el rechazo de órganos trasplantados; se usa especialmente en ...

sirolimus etkin maddesi - İlacabak - İLAÇ REHBERİNİZ

sirolimus etkin maddesi hakkında kısa bilgi. İmmünosupresan. Yetişkinde 6-15mg yükleme, sonra günde 2-5mg. Kontrendikasyon; aşırı duyarlılık.

Sirolimus - Wirkstoff - sanego Gesundheitsportal ...

Wirkstoff Sirolimus; Erfahrungsberichte: 4; Medikamente: Rapamune; Nebenwirkungen: Blutfetterhöhung, Infektanfälligkeit, Magnesiummangel,…

Efficacy and Safety of Sirolimus in ...

Background Lymphangioleiomyomatosis (LAM) is a progressive, cystic lung disease in women; it is associated with inappropriate activation of mammalian target of ...

Rapamycin (AY 22989 NSC 2260804 Sirolimus) TLR signaling ...

mTOR inhibitor and Autophagy Inducer: Rapamycin is an inhibitor of the Ser/Thr protein kinase mTOR (mammalian target of rapamycin), which regulates cell growth and ...

PharmaWiki - Sirolimus (Rapamycin)

Sirolimus (Rapamycin) Arzneimittelgruppen Immunsuppressiva Kinasehemmer mTOR-Inhibitoren Sirolimus ist ein Wirkstoff aus der Gruppe der Immunsuppressiva, der zur ...